Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA)

Authors

U. Prothmann
Klaus Krueger
O. Behmer
F. Behrens
Pascal Klaus
J. Detert
Martin Feuchtenberger (ORCID: https://orcid.org/0000-0001-8028-8099)
Thomas Meng
J Jobst
Min-Jean Marianne Hsieh
Jan Brandt-Juergens

Institutions

Knappschaftsklinikum Saar (DE)
Pfizer (Germany) (DE)
Knappschaftskrankenhaus Recklinghausen (DE)
Cardiovascular Center Frankfurt (DE)
Orthopädische Praxis (DE)
Medias Klinikum (DE)
Praxis (EE)

Publication Details

Journal: BMJ Open
Published: 2026-02-01
DOI: https://doi.org/10.1136/bmjopen-2024-096952
Primary Topic: Rheumatoid Arthritis Research and Therapies
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Amgen
Eli Lilly and Company
Pfizer
Sanofi
Gilead Sciences
Biogen
Celltrion
Sun Pharma
Medac
Chugai Pharmaceutical
Cilag

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA)

U. Prothmann, Klaus Krueger, O. Behmer, F. Behrens et al.

Feb 1, 2026

BMJ Open

Rheumatoid Arthritis Research and Therapies

article

Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA)

U. Prothmann, Klaus Krueger, O. Behmer, F. Behrens, Pascal Klaus, J. Detert, Martin Feuchtenberger, Thomas Meng, J Jobst, Min-Jean Marianne Hsieh, Jan Brandt-Juergens

February 1, 2026article en

Abstract

No abstract available for this paper.

BMJ OpenVol. 16(2)

Knappschaftsklinikum Saar (DE), Pfizer (Germany) (DE), Knappschaftskrankenhaus Recklinghausen (DE), Cardiovascular Center Frankfurt (DE), Orthopädische Praxis (DE), Medias Klinikum (DE), Praxis (EE)

Amgen, Eli Lilly and Company, Pfizer, Sanofi, Gilead Sciences, Biogen, Celltrion, Sun Pharma, Medac, Chugai Pharmaceutical, Cilag

Good health and well-being

Openalex Percentile: Top 60%

Rheumatoid Arthritis Research and Therapies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.